|
1) ASGE SoPC, Anderson MA, Ben-Menachem T, et al. Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc. 2009; 70: 1060-70
|
|
|
|
2) Becker RC, Scheiman J, Dauerman HL, et al. Management of platelet-directed pharmaco-therapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. Am J Gastroenterol. 2009; 104: 2903-17
|
|
|
|
|
|
3) Becker RC, Scheiman J, Dauerman HL, et al. Management of platelet-directed pharmaco-therapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. J Am Coll Cardiol. 2009; 54: 2261-76
|
|
|
|
|
|
4) Barkun AN, Bardou M, Kuipers EJ, et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2010; 152: 101-13
|
|
|
|
|
|
5) Boustière C, Veitch A, Vanbiervliet G, et al. Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2011; 43: 445-61
|
|
|
|
|
|
6) Yasue H, Ogawa H, Tanaka H, et al. Effects of aspirin and trapidil on cardiovascular events after acute myocardial infarction. Japanese Antiplatelets Myocardial Infarction Study (JAMIS) Investigators. Am J Cardiol. 1999; 83: 1308-13
|
|
|
|
|
|
7) Ogawa H, Nakayama M, Morimoto T, et al. Low-dose aspirin for primary prevention of athero-sclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA. 2008; 300: 2134-41
|
|
|
|
|
|
8) Hokimoto S, Matsui K, Ogawa H, et al. Effects of gastric medicines on gastroduodenal injury in patients with stable angina during antiplatelet therapy. J Cardiol. 2009; 54: 71-5
|
|
|
|
|
9) Kimura T, Morimoto T, Nakagawa Y, et al; j-Cypher Registry Investigators. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation. 2009; 119: 987-95
|
|
|
|
|